Role and Mechanism of MiR-187 in Human Cancer

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2020 Oct 12

PMID 33042395

Citations 6

Authors

Weiwei Peng

Huanhuan Sha

Xun Sun

Renrui Zou

Yue Zhu

Guoren Zhou

Jifeng Feng

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are short non-coding RNAs, approximately 22 nucleotides in length, and involved in the post-transcriptional regulation of gene expression. MiRNAs play fundamental roles in many biological processes such as the development and progression of tumors. In this review, we briefly describe the expression of miR-187 in various types of cancer and discuss the role of miR-187 in cancer development and drug resistance. It is also possible to take miR-187 as an important indicator of diagnosis and prognosis of tumors.

Citing Articles

LncIMF1 Promotes Adipogenesis of Porcine Intramuscular Preadipocyte by Sponging miR-187.

Feng M, Yi X, Zhang Z, Zhu J, Yu H, Ming L Biochem Genet. 2025; .

PMID: 39961961 DOI: 10.1007/s10528-025-11061-y.

Identification of Novel 58-5p and Interaction and Effects on Apoptosis of Ovine Ovarian Granulosa Cell.

Yang R, Wang Y, Yue S, Liu Y, Zhang Y, Duan C Int J Mol Sci. 2025; 26(2).

PMID: 39859292 PMC: 11765093. DOI: 10.3390/ijms26020576.

Zishen Yutai Pills Promote Angiogenesis at the Maternal-Fetal Interface in Recurrent Spontaneous Abortion Mice by Regulating miR-187/VEGF Axis.

Wang X, Hu H, Yu X, Liang C, Han Y, Chen H Drug Des Devel Ther. 2024; 18:407-423.

PMID: 38370565 PMC: 10871043. DOI: 10.2147/DDDT.S436718.

Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles.

Mondal D, Shinde S, Paul S, Thakur S, Velu G, Tiwari A Front Oncol. 2023; 13:1230273.

PMID: 37637043 PMC: 10448964. DOI: 10.3389/fonc.2023.1230273.

Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes.

Shayeghpour A, Forghani-Ramandi M, Solouki S, Hosseini A, Hosseini P, Khodayar S Infect Agent Cancer. 2023; 18(1):12.

PMID: 36841815 PMC: 9968414. DOI: 10.1186/s13027-023-00492-0.

References

Danese E, Montagnana M, Lippi G . Circulating molecular biomarkers for screening or early diagnosis of colorectal cancer: which is ready for prime time?. Ann Transl Med. 2020; 7(21):610. PMC: 7011594. DOI: 10.21037/atm.2019.08.97. View

Uhr K, Prager-van der Smissen W, Heine A, Ozturk B, van Jaarsveld M, Boersma A . MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines. PLoS One. 2019; 14(5):e0216400. PMC: 6504094. DOI: 10.1371/journal.pone.0216400. View

Kiselev F . [MicroRNA and cancer]. Mol Biol (Mosk). 2015; 48(2):232-42. View

Laufs V, Altieri B, Sbiera S, Kircher S, Steinhauer S, Beuschlein F . ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas. Eur J Endocrinol. 2017; 178(2):181-188. DOI: 10.1530/EJE-17-0788. View

Zhu Q, Li Z, Lv C, Wang W . MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway. Eur Rev Med Pharmacol Sci. 2019; 23(22):9907-9914. DOI: 10.26355/eurrev_201911_19556. View

Xiao Y, Zhao Q, Du B, Chen H, Zhou D . MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4. Cancer Invest. 2018; 36(1):1-9. DOI: 10.1080/07357907.2017.1415348. View

Han X, Wang X, Zhao B, Chen G, Sheng Y, Wang W . MicroRNA-187 inhibits tumor growth and metastasis via targeting of IGF-1R in hepatocellular carcinoma. Mol Med Rep. 2017; 16(2):2241-2246. DOI: 10.3892/mmr.2017.6788. View

Dehghanzadeh R, Jadidi-Niaragh F, Gharibi T, Yousefi M . MicroRNA-induced drug resistance in gastric cancer. Biomed Pharmacother. 2015; 74:191-9. DOI: 10.1016/j.biopha.2015.08.009. View

Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F . MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6. Biochem Biophys Res Commun. 2016; 471(1):82-8. DOI: 10.1016/j.bbrc.2016.01.175. View

10.

Li C, Lu S, Shi Y . MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2. Oncol Rep. 2017; 37(3):1747-1755. DOI: 10.3892/or.2017.5370. View

11.

Mao M, Wu Z, Chen J . MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1. Biochem Biophys Res Commun. 2016; 478(2):649-55. DOI: 10.1016/j.bbrc.2016.08.001. View

12.

Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B . The relation between PI3K/AKT signalling pathway and cancer. Gene. 2019; 698:120-128. DOI: 10.1016/j.gene.2019.02.076. View

13.

Kosaka N, Iguchi H, Ochiya T . Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010; 101(10):2087-92. PMC: 11159200. DOI: 10.1111/j.1349-7006.2010.01650.x. View

14.

Schultz N, Andersen K, Roslind A, Willenbrock H, Wojdemann M, Johansen J . Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index. World J Surg. 2012; 36(11):2699-707. DOI: 10.1007/s00268-012-1705-y. View

15.

Khan A, Ahmed E, Elareer N, Junejo K, Steinhoff M, Uddin S . Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies. Cells. 2019; 8(8). PMC: 6721829. DOI: 10.3390/cells8080840. View

16.

Zucali P, Giovannetti E, Destro A, Mencoboni M, Ceresoli G, Gianoncelli L . Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin. Clin Cancer Res. 2011; 17(8):2581-90. DOI: 10.1158/1078-0432.CCR-10-2873. View

17.

Martinez-Gutierrez A, Millan Catalan O, Vazquez-Romo R, Porras Reyes F, Alvarado-Miranda A, Lara Medina F . miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments. Int J Mol Med. 2019; 44(4):1267-1280. PMC: 6713405. DOI: 10.3892/ijmm.2019.4292. View

18.

Blazek J, Ottomann C, Muehlberger T . [Pharmacological therapy of keloids in an athymic mouse model]. Handchir Mikrochir Plast Chir. 2008; 40(2):81-7. DOI: 10.1055/s-2007-965477. View

19.

Fei D, Zhao K, Yuan H, Xing J, Zhao D . MicroRNA-187 exerts tumor-suppressing functions in osteosarcoma by targeting ZEB2. Am J Cancer Res. 2017; 6(12):2859-2868. PMC: 5199759. View

20.

Lv Y, Duanmu J, Fu X, Li T, Jiang Q . Identifying a new microRNA signature as a prognostic biomarker in colon cancer. PLoS One. 2020; 15(2):e0228575. PMC: 7015317. DOI: 10.1371/journal.pone.0228575. View